A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600–Mutant Solid TumorsClinton Yam, Tara C. Gangadhar, Michael A. Davies et al.|Clinical Cancer Research|2017Cited by 38